Gandhi Mayank 4
4 · eFFECTOR Therapeutics, Inc. · Filed Sep 28, 2022
Insider Transaction Report
Form 4
Gandhi Mayank
Chief Business Officer
Transactions
- Award
Stock Option (Right to Buy)
2022-09-26+500,000→ 500,000 totalExercise: $0.56Exp: 2032-09-25→ Common Stock (500,000 underlying)
Footnotes (1)
- [F1]The stock option vests 25% on September 26, 2023, and in 36 monthly installments thereafter, subject to the Reporting Person's continued service through the applicable vesting date.